Increased Circulating Concentrations of Growth-related Oncogene (GRO)-alpha in Patients with Inflammatory Bowel Disease

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2006 Jan 18

PMID 16416232

Citations 22

Authors

Keiichi Mitsuyama

Osamu Tsuruta

Nobuo Tomiyasu

Kosuke Takaki

Asuka Suzuki

Junya Masuda

Hiroshi Yamasaki

Atsushi Toyonaga

Michio Sata

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory state associated with increased risk of intestinal cancers. The aim of this study is to examine serum concentrations of growth-related oncogene (GRO)-alpha, a cytokine with inflammatory and growth-regulatory properties, in patients with IBD. We measured serum concentrations of GRO-alpha in 60 patients with ulcerative colitis, 42 patients with Crohn's disease, 16 patients with other colitides, 12 patients with colorectal cancer, and 40 normal subjects using an enzyme-linked immunosorbent assay. We then analyzed how the cytokine was related to clinical and laboratory variables. Serum GRO-alpha concentrations in patients with active IBD were significantly higher than those in patients with quiescent disease, which in turn were higher than those in normal controls. Concentrations in patients with active ulcerative colitis were higher than in patients with active Crohn's disease. Analysis of paired serum samples showed a decrease in GRO-alpha after initiation of therapy. Furthermore, serum GRO-alpha correlated well with laboratory markers of IBD activity. We conclude that GRO-alpha may have an important role in development of IBD, and might itself be used as a marker of activity. Manipulation of GRO-alpha function might prove therapeutically useful.

Citing Articles

An model to study immune activation, epithelial disruption and stromal remodelling in inflammatory bowel disease and fistulising Crohn's disease.

Mobbs C, Darling N, Przyborski S Front Immunol. 2024; 15:1357690.

PMID: 38410518 PMC: 10894943. DOI: 10.3389/fimmu.2024.1357690.

Infection and inflammation stimulate expansion of a CD74 Paneth cell subset to regulate disease progression.

Balasubramanian I, Bandyopadhyay S, Flores J, Bianchi-Smak J, Lin X, Liu H EMBO J. 2023; 42(21):e113975.

PMID: 37718683 PMC: 10620768. DOI: 10.15252/embj.2023113975.

The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.

Korbecki J, Szatkowska I, Kupnicka P, Zwierello W, Barczak K, Poziomkowska-Gesicka I Int J Mol Sci. 2022; 23(13).

PMID: 35806156 PMC: 9266754. DOI: 10.3390/ijms23137151.

Endoplasmic reticulum stress contributed to inflammatory bowel disease by activating p38 MAPK pathway.

Long Y, Zhao Y, Ma X, Zeng Y, Hu T, Wu W Eur J Histochem. 2022; 66(2).

PMID: 35603939 PMC: 9178311. DOI: 10.4081/ejh.2022.3415.

Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer.

Hamade D, Espinal A, Yu J, Leibowitz B, Fisher R, Hou W Radiat Res. 2022; 198(1):89-105.

PMID: 35446961 PMC: 9278541. DOI: 10.1667/RADE-21-00224.1.

References

Mahida Y, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey C . Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond). 1992; 82(3):273-5. DOI: 10.1042/cs0820273. View

Schroder J, Persoon N, Christophers E . Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med. 1990; 171(4):1091-100. PMC: 2187842. DOI: 10.1084/jem.171.4.1091. View

Watanabe K, Kinoshita S, Nakagawa H . Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun. 1989; 161(3):1093-9. DOI: 10.1016/0006-291x(89)91355-7. View

Loukinova E, Dong G, Thomas G, Chen Z, Schreiber H, Van Waes C . Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene. 2000; 19(31):3477-86. DOI: 10.1038/sj.onc.1203687. View

Raab Y, Gerdin B, Ahlstedt S, Hallgren R . Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut. 1993; 34(9):1203-6. PMC: 1375454. DOI: 10.1136/gut.34.9.1203. View

Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H . The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem. 1989; 264(33):19559-63. View

Kojima T, Cromie M, Fisher G, Voorhees J, Elder J . GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol. 1993; 101(6):767-72. DOI: 10.1111/1523-1747.ep12371692. View

Poullis A, Zar S, Sundaram K, Moodie S, Risley P, Theodossi A . A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol. 2002; 14(4):409-12. DOI: 10.1097/00042737-200204000-00013. View

Munkholm P . Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003; 18 Suppl 2:1-5. DOI: 10.1046/j.1365-2036.18.s2.2.x. View

10.

Mahida Y, Kurlac L, Gallagher A, Hawkey C . High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut. 1991; 32(12):1531-4. PMC: 1379256. DOI: 10.1136/gut.32.12.1531. View

11.

Lashner B, Silverstein M, Hanauer S . Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci. 1989; 34(10):1536-41. DOI: 10.1007/BF01537106. View

12.

TRUELOVE S, Witts L . Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955; 2(4947):1041-8. PMC: 1981500. DOI: 10.1136/bmj.2.4947.1041. View

13.

Isaacs K, Sartor R, Haskill S . Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology. 1992; 103(5):1587-95. DOI: 10.1016/0016-5085(92)91182-4. View

14.

Izzo R, Witkon K, Chen A, Hadjiyane C, Weinstein M, Pellecchia C . Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol. 1992; 87(10):1447-52. View

15.

Oppenheim J, Zachariae C, Mukaida N, Matsushima K . Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991; 9:617-48. DOI: 10.1146/annurev.iy.09.040191.003153. View

16.

Watanabe K, Nakagawa H . Production of a chemotactic factor for polymorphonuclear leukocytes by epithelioid cells from rat renal glomeruli in culture. Biochem Biophys Res Commun. 1987; 149(3):989-94. DOI: 10.1016/0006-291x(87)90506-7. View

17.

Myren J, Bouchier I, Watkinson G, Softley A, Clamp S, de Dombal F . The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol Suppl. 1984; 95:1-27. View

18.

Anisowicz A, Bardwell L, Sager R . Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci U S A. 1987; 84(20):7188-92. PMC: 299255. DOI: 10.1073/pnas.84.20.7188. View

19.

Lane B, Liu J, Bock P, Schols D, Coffey M, Strieter R . Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. J Virol. 2002; 76(22):11570-83. PMC: 136744. DOI: 10.1128/jvi.76.22.11570-11583.2002. View

20.

Papadakis K . Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep. 2003; 4(1):83-9. DOI: 10.1007/s11882-004-0048-7. View